| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/21/2007 | WO2007068842A1 Use of a dermatological composition comprising an association of hydroquinone, fluocinolone acetonide and tretinoin, in combination with the application of laser or pulsed flash lamp radiation for treating acquired dermal melanocytosis |
| 06/21/2007 | WO2007068841A2 Use of a composition based on tretinoin, hydroquinone and fluocinolone acetonide, accompanied by a chemical peeling |
| 06/21/2007 | WO2007068757A1 Food supplement based on group b vitamins, trace elements and w-3 and/or w-6 fatty acids and use of this food supplement in the simultaneous treatment of localized cellulite and slackening of the skin |
| 06/21/2007 | WO2007068743A1 Use of polyunsaturated compounds as whitening agents |
| 06/21/2007 | WO2007068704A1 Anti-myosin va sirna and skin depigmentation |
| 06/21/2007 | WO2007068580A1 Biphenyl derivatives as selective agonists of gamma rar receptor |
| 06/21/2007 | WO2007068579A1 Biphenyl derivatives as selective agonists of gamma rar receptors |
| 06/21/2007 | WO2007068577A1 Use of naveglitazar for preparing a pharmaceutical composition for use in the treatment of dermatological conditions |
| 06/21/2007 | WO2007068171A1 CRYSTALLINE FORM I OF 3,4',5-TRIHYDROXY-STIBENE-3-β-D-GLUCOSIDE |
| 06/21/2007 | WO2007039821A3 Novel inhibitors of tyrosinase, their method of preparation and their use in human medicine and in cosmetics |
| 06/21/2007 | WO2007031621B1 Metronidazole-based dermatological foam and emulsions for the production thereof |
| 06/21/2007 | WO2007029121A3 Novel cyclopent-2-en-1-one derivatives which are ppar receptor modulators, and use thereof in pharmaceutical or cosmetic compositions |
| 06/21/2007 | WO2007023226A3 Use of a symbiotic for the treatment of atopic dermatitis |
| 06/21/2007 | WO2007018846A3 Use of interferon- tau for reduction of scar tissue formation |
| 06/21/2007 | WO2006119300A3 Method of using oxidative reductive potential water solution in dental applications |
| 06/21/2007 | WO2002100330A9 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 06/21/2007 | US20070143871 Non-human transgenic animal models for hepatocellular carcinoma |
| 06/21/2007 | US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors |
| 06/21/2007 | US20070142470 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 06/21/2007 | US20070142465 Macrophage activation inhibitor |
| 06/21/2007 | US20070142449 Angiogenesis inhibitors |
| 06/21/2007 | US20070142352 Pteridinone Derivatives as Modulators of Chemokine Receptor Activity |
| 06/21/2007 | US20070142344 fluocinonide or fluocinonide acetonide topical with two or more penetration enhancers |
| 06/21/2007 | US20070142343 Mixture with penetration intensifiers, solvents and emulsifiers |
| 06/21/2007 | US20070142342 Pharmaceutical compounds |
| 06/21/2007 | US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ |
| 06/21/2007 | US20070142334 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 06/21/2007 | US20070142320 Using water insoluble microparticulate glucans comprising branched beta -(1,3)(1,6) glucan, essentially free of unbranched beta -(1,3)(1,6) glucan and non-glucan components |
| 06/21/2007 | US20070142314 Administering a nucleotide decoy of an ets gene or a chimera decoy of NF-Kappa B with a hydrophillic polymer carrier sheet; aneurysm, Marfan's syndrome, aortic detachment, and plaque rupture |
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070141173 Medicament comprising noble metal fine particles |
| 06/21/2007 | US20070141020 Use of biocompatible polymers for the preparation of a composition or a medical device |
| 06/21/2007 | US20070141017 Penetration enhancing agent and method of its production from the hemp seeds |
| 06/21/2007 | US20070141000 e.g. L-Ascorbic acid-2-phosphoric acid-6-(2'-hexyldecanoate) sodium salt; collagen production accelerators; skin whitening; medical, pharmaceutical preparations, feeds, foods and agrochemicals; storage stability, |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | DE202007004901U1 Pflege- und Heilöl zur Behandlung trockener, wunder, stark beanspruchter und strahlengeschädigter Haut Care and healing oil for treating dry, sore, stretched and radiation-damaged skin |
| 06/21/2007 | DE202007003020U1 Zusammensetzung als Pharmazeutika, Desinfektionsmittel, Pflege- und Hygienemittel oder Wundmittel Composition as pharmaceuticals, disinfectants, care and hygiene products or wound means |
| 06/21/2007 | CA2633497A1 Use of polyunsaturated compounds as whitening agents |
| 06/21/2007 | CA2633374A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | CA2632910A1 Biphenyl derivatives as selective agonists of gamma rar receptor |
| 06/21/2007 | CA2632899A1 Biphenyl derivatives as selective agonists of gamma rar receptors |
| 06/21/2007 | CA2632894A1 Use of a dermatological composition comprising an association of hydroquinone, fluocinolone acetonide and tretinoin for treating skin hyperpigmentation following psoriasis or eczema |
| 06/21/2007 | CA2632876A1 Bovine osteopontin formulations for the improvement of the wound healing process |
| 06/21/2007 | CA2632837A1 Anti-myosin va sirna and skin depigmentation |
| 06/21/2007 | CA2632466A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/20/2007 | EP1798242A2 New anti-GF-IR antibodies and their applications |
| 06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
| 06/20/2007 | EP1798229A1 Substituted biphenyl derivative |
| 06/20/2007 | EP1798226A1 Triazole derivative |
| 06/20/2007 | EP1798221A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 06/20/2007 | EP1797082A1 Carbostyril compound |
| 06/20/2007 | EP1797053A1 Wound healing |
| 06/20/2007 | EP1797033A2 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof |
| 06/20/2007 | EP1796646A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 06/20/2007 | EP1796636A1 Microemulsion & sub-micron emulsion process & compositions |
| 06/20/2007 | EP1706127B1 Penetration enhancing agent and method of its production from the hemp seeds |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1272204B1 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 06/20/2007 | CN1984899A CXCR1 and CXCR2 chemokine antagonists |
| 06/20/2007 | CN1984650A Hair growth promoting agents |
| 06/20/2007 | CN1981865A Formula and usage for treating acne |
| 06/20/2007 | CN1981862A Foot nursing cream and its production |
| 06/20/2007 | CN1981846A Enzyme inhibiting sprayable skin barrier compositions |
| 06/20/2007 | CN1981845A Chinese-medicinal composition, its production and use |
| 06/20/2007 | CN1981842A Medicinal liquor for treating malignant boil |
| 06/20/2007 | CN1981834A Ointment for treating wound |
| 06/20/2007 | CN1981815A Hand and foot antibacterial detergent and its production |
| 06/20/2007 | CN1981798A Multi-purpose shenji plaster |
| 06/20/2007 | CN1981788A Medicinal liquor for treating sore swollen toxin |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981771A Ointement for treating ringworm |
| 06/20/2007 | CN1981769A Hydrochloride epinastine dispersing tablets and their production |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1322002C Methylene-4-azasteroids |
| 06/20/2007 | CN1321702C Wound dressing for first aid |
| 06/20/2007 | CN1321689C Use of disintegrain domain of adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321687C Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/20/2007 | CN1321683C Use of neurotoxin therapy for treatment of urologic and related disorders |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321669C Chinese herbal medicine for treating urticaria |
| 06/20/2007 | CN1321668C External use liquid medicine |
| 06/20/2007 | CN1321665C Combination of medication by using beartyberry and dragon's blood resin as combination of activities |
| 06/20/2007 | CN1321647C Medicine for wound healing and preparation method thereof |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321633C Treatment of nail infections using NO generating compositions |
| 06/20/2007 | CN1321627C Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232881 Peptide containing Ser-Ser-Ser-Arg |
| 06/19/2007 | US7232844 Insect repellent compounds |
| 06/19/2007 | US7232827 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives |
| 06/19/2007 | US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 06/19/2007 | US7232814 Heterocyclic carboxy amines such as 9-nitro-7,12-dihydroindolo (3,2-d)(1)-benzazepin-6(5H)-one, used as inhibitors of glycogen synthase kinase-3 beta or cyclin dependent kinases |
| 06/19/2007 | US7232804 Use of KPV tripeptide for dermatological disorders |
| 06/19/2007 | CA2166179C Use of a tnf-alpha antagonist in a cosmetic, pharmaceutical or skincare composition and composition thus obtained |
| 06/16/2007 | WO2007070067A1 Regeneration of vaginal tissue with non-systemic vaginal administration of estrogen |
| 06/14/2007 | WO2007066928A1 Use of the extract of caesalpinia sappan l. and compounds therefrom |